Clinical Trial Update: Bioequivalence Study Comparing Artesunate Tablet To Arsuamoon® Tablets (Guilin-China) In Healthy Subjects [Phase 1]

View source ↗

Summary

Pfizer-sponsored Phase 1 bioequivalence study in healthy subjects completed, comparing Artesunate tablets with Arsuamoon tablets in Guilin, China, to assess pha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Falciparum Malaria

Drugs mentioned

• Arsuamoon tablets (artesunate)
• Artesunate tablets (artesunate)

Snippet

Sponsor: Pfizer | Conditions: Falciparum Malaria | Phase 1 | Status: COMPLETED